Page last updated: 2024-11-07

spironolactone and Myxedema

spironolactone has been researched along with Myxedema in 1 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Myxedema: A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kokenge, F1
Liedtke, R1
Zepf, S1

Other Studies

1 other study available for spironolactone and Myxedema

ArticleYear
[A contribution on diagnostic and therapy of myxoedema coma (author's transl)].
    Medizinische Klinik, 1975, Aug-01, Volume: 70, Issue:31

    Topics: Aged; Coma; Female; Humans; Hyperaldosteronism; Myxedema; Remission, Spontaneous; Spironolactone; Tr

1975